SOUTH SAN FRANCISCO, Calif. (AP) _ Cytokinetics Inc. (CYTK) on Thursday reported a loss of $29.4 million in its first quarter.
The South San Francisco, California-based company said it had a loss of 54 cents per share.
The biopharmaceutical company posted revenue of $8.5 million in the period.
Cytokinetics shares have increased 43% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.03, a climb of slightly more than 1% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK